U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Unknown
149124
Substance Class Protein
Created
by admin
on Wed Apr 02 09:59:45 GMT 2025
Edited
by admin
on Wed Apr 02 09:59:45 GMT 2025
Protein Sub Type
Sequence Type COMPLETE
Record UNII
IT063R5MY0
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
EPTOTERMIN ALFA
EMA EPAR   INN   MART.   WHO-DD  
INN  
Official Name English
RH-POLYPEPTIDE-52
INCI  
INCI  
Preferred Name English
EPTOTERMIN ALFA [EMA EPAR]
Common Name English
OSIGRAFT
Brand Name English
BONE MORPHOGENETIC PROTEIN 7
Common Name English
HBMP7
Brand Name English
eptotermin alfa [INN]
Common Name English
EPTOTERMIN ALFA [MART.]
Common Name English
OSTEOGENIC PROTEIN 1
Common Name English
HUMAN RECOMBINANT BONE MORPHOGENETIC PROTEIN 7
Common Name English
BMP-7
Common Name English
OP-1
Common Name English
OPGENRA
Brand Name English
Eptotermin Alfa [WHO-DD]
Common Name English
Classification Tree Code System Code
WHO-ATC M05BC02
Created by admin on Wed Apr 02 09:59:45 GMT 2025 , Edited by admin on Wed Apr 02 09:59:45 GMT 2025
WHO-VATC QM05BC02
Created by admin on Wed Apr 02 09:59:45 GMT 2025 , Edited by admin on Wed Apr 02 09:59:45 GMT 2025
EMA ASSESSMENT REPORTS OPGENRA (AUTHORIZED: SPONDYLOLISTHESIS)
Created by admin on Wed Apr 02 09:59:45 GMT 2025 , Edited by admin on Wed Apr 02 09:59:45 GMT 2025
EMA ASSESSMENT REPORTS OSIGRAFT (AUTHORIZED: TIBIAL FRACTURES)
Created by admin on Wed Apr 02 09:59:45 GMT 2025 , Edited by admin on Wed Apr 02 09:59:45 GMT 2025
Code System Code Type Description
CAS
129805-33-0
Created by admin on Wed Apr 02 09:59:45 GMT 2025 , Edited by admin on Wed Apr 02 09:59:45 GMT 2025
PRIMARY
DRUG CENTRAL
5175
Created by admin on Wed Apr 02 09:59:45 GMT 2025 , Edited by admin on Wed Apr 02 09:59:45 GMT 2025
PRIMARY
EVMPD
SUB20066
Created by admin on Wed Apr 02 09:59:45 GMT 2025 , Edited by admin on Wed Apr 02 09:59:45 GMT 2025
PRIMARY
INN
7989
Created by admin on Wed Apr 02 09:59:45 GMT 2025 , Edited by admin on Wed Apr 02 09:59:45 GMT 2025
PRIMARY
ChEMBL
CHEMBL2108594
Created by admin on Wed Apr 02 09:59:45 GMT 2025 , Edited by admin on Wed Apr 02 09:59:45 GMT 2025
PRIMARY
MESH
D055419
Created by admin on Wed Apr 02 09:59:45 GMT 2025 , Edited by admin on Wed Apr 02 09:59:45 GMT 2025
PRIMARY
SMS_ID
100000089545
Created by admin on Wed Apr 02 09:59:45 GMT 2025 , Edited by admin on Wed Apr 02 09:59:45 GMT 2025
PRIMARY
NCI_THESAURUS
C170404
Created by admin on Wed Apr 02 09:59:45 GMT 2025 , Edited by admin on Wed Apr 02 09:59:45 GMT 2025
PRIMARY
FDA UNII
IT063R5MY0
Created by admin on Wed Apr 02 09:59:45 GMT 2025 , Edited by admin on Wed Apr 02 09:59:45 GMT 2025
PRIMARY
DRUG BANK
DB11631
Created by admin on Wed Apr 02 09:59:45 GMT 2025 , Edited by admin on Wed Apr 02 09:59:45 GMT 2025
PRIMARY
From To
1_38 1_104
1_67 1_136
1_71 1_138
1_103 2_103
2_38 2_104
2_67 2_136
2_71 2_138
Glycosylation Type MAMMALIAN
Glycosylation Link Type Site
N 1_10
N 1_29
N 1_80
N 2_10
N 2_29
N 2_80
Related Record Type Details
ACTIVIN RECEPTOR TYPE-2A
TARGET -> AGONIST
Type I receptor ACVR1, type II receptor ACVR2A and BMP-7 agonist proteins must form a complex to initiate the canonical BMP signaling cascade.
ACTIVIN RECEPTOR TYPE-1
TARGET -> AGONIST
Type I receptor ACVR1, type II receptor ACVR2A and BMP-7 agonist proteins must form a complex to initiate the canonical BMP signaling cascade.
Related Record Type Details
EPTOTERMIN ALFA
ACTIVE MOIETY
Name Property Type Amount Referenced Substance Defining Parameters References
MOL_WEIGHT:NUMBER(CALCULATED) CHEMICAL
Molecular Formula CHEMICAL
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966